Scholarlink

<p>Deciphering evolutionary drivers of biosynthetic pathways could enhance bioactive compound production. In <i>Angelica</i>, interspecific variation in furanocoumarins (FCs) accumulation reflects divergent pathway evolution. Here, we conduct comparative genomics between high-FC <i>Angelica</i> sensu stricto (s.s.) and low-FC <i>Angelica</i> sensu lato (s.l.) species. We reveal an FC biosynthetic gene cluster (BGC) comprising core enzymes (<i>p</i>-coumaroyl-CoA 2’-hydroxylases (C2’Hs), prenyltransferases (PTs)) and peripheral O<i>-</i>methyltransferases (OMTs). The ancestral <i>Angelica</i> s.l. clade retains an FC BGC configuration with OMTs on separate chromosomes and PTs performing only C-prenylation. In contrast, <i>Angelica</i> s.s. evolves an FC BGC, where core enzymes and OMTs co-localise on the same chromosome, with C2’H copy number expansion correlating with elevated expression and PTs enabling both C- and O-prenylation, collectively enhancing FC production and structural diversity. These findings elucidate how BGC architecture, gene copy number and functional innovation collectively drive phytochemical innovation, providing a blueprint for engineering medicinal FC biosynthesis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evolutionary tuning of a biosynthetic gene cluster drives furanocoumarin accumulation and diversification

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Xiaoxu Han,
  • Miaoxian Guo,
  • Peng Yang,
  • Donghua Hu,
  • Yuanxia Chen,
  • Yujie Jia,
  • Hongcui Pei,
  • Jiantao Tan,
  • Elsayed Nishawy,
  • Zefu Lu,
  • Anthony Twamley,
  • Garth Maker,
  • Li Wang

摘要

Deciphering evolutionary drivers of biosynthetic pathways could enhance bioactive compound production. In Angelica, interspecific variation in furanocoumarins (FCs) accumulation reflects divergent pathway evolution. Here, we conduct comparative genomics between high-FC Angelica sensu stricto (s.s.) and low-FC Angelica sensu lato (s.l.) species. We reveal an FC biosynthetic gene cluster (BGC) comprising core enzymes (p-coumaroyl-CoA 2’-hydroxylases (C2’Hs), prenyltransferases (PTs)) and peripheral O-methyltransferases (OMTs). The ancestral Angelica s.l. clade retains an FC BGC configuration with OMTs on separate chromosomes and PTs performing only C-prenylation. In contrast, Angelica s.s. evolves an FC BGC, where core enzymes and OMTs co-localise on the same chromosome, with C2’H copy number expansion correlating with elevated expression and PTs enabling both C- and O-prenylation, collectively enhancing FC production and structural diversity. These findings elucidate how BGC architecture, gene copy number and functional innovation collectively drive phytochemical innovation, providing a blueprint for engineering medicinal FC biosynthesis.